Jacobio Pharma Announces 2024 Annual Results

BEIJING,SHANGHAI and BOSTON,March 19,2025-- Jacobio Pharma (1167.HK) released its 2024 annual results,with revenue of RMB160million,R&D expense of RMB330 million. Major operating and financing act

Home Previous 11 12 13 14 15 16 17 Next Tail

10 Items Per Page (Page 14 / 156) Total 1557 Items

©copyright2009-2020 British Weekly      Contact Us   SiteMap